World's Best Scientists 2026 revealed!
Marc Schmitz

Marc Schmitz

D-Index & Metrics

Immunology

D-Index
64
Citations
11243
World Ranking
2970
National Ranking
198

Marc Schmitz publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Marc Schmitz sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 216 publications — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Marc Schmitz D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Marc Schmitz sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 64 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Marc Schmitz is affiliated with TU Dresden in Germany and focuses on research within the fields of Medicine, Immunology, and Microbiology. Their work predominantly addresses oncology and immunology, with additional contributions in molecular biology, surgery, and genetics. The scientist's research extensively covers cancer immunotherapy, immune responses, and the role of immune cells in cancer.

The main topics in their research include:

  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • Immune cells in cancer
  • Pancreatic and Hepatic Oncology Research
  • Bladder and Urothelial Cancer Treatments

Marc Schmitz has published a significant number of papers, with notable recent contributions such as:

  • Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia, 2020, Science Translational Medicine
  • Immunomodulatory Properties of Mesenchymal Stromal Cells: An Update, 2021, Frontiers in Cell and Developmental Biology
  • Anti-PD-1 and Novel Combinations in the Treatment of Melanoma-An Update, 2020, Journal of Clinical Medicine
  • Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human colon cancer, 2021, Journal for ImmunoTherapy of Cancer
  • Bidirectional Crosstalk Between Cancer Stem Cells and Immune Cell Subsets, 2020, Frontiers in Immunology

Frequent co-authors collaborating with Marc Schmitz include:

  • Rebekka Wehner
  • Luise Rupp
  • Antje Tunger
  • Luise Müller
  • Michael Bachmann

Their research is regularly published in journals such as:

  • Frontiers in Immunology
  • Cancers
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Blood
  • Journal of Clinical Oncology

Best Publications

  • Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium

    M von Bonin;F Stölzel;A Goedecke;K Richter

  • Generation of survivin-specific CD8+ T effector cells by dendritic cells pulsed with protein or selected peptides.

    Marc Schmitz;Petra Diestelkoetter;Bernd Weigle;Florian Schmachtenberg

  • Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong Th17/Th1 T-cell responses

    Anja Hänsel;Claudia Günther;Jens Ingwersen;Josephine Starke

  • Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy

    M Schmitz;A Temme;V Senner;R Ebner

  • Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders

    Senming Zhao;Rebekka Wehner;Martin Bornhäuser;Ralf Wassmuth

  • Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma

    Nadja Müller;Susanne Michen;Stefanie Tietze;Katrin Töpfer

  • Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer

    Marc Cartellieri;Michael Bachmann;Anja Feldmann;Claudia Bippes

  • Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients.

    Jacques Rohayem;Petra Diestelkoetter;Bernd Weigle;Antje Oehmichen

  • Enhancement of T Cell Receptor Signaling by a Mild Oxidative Shift in the Intracellular Thiol Pool

    S P Hehner;R Breitkreutz;G Shubinsky;H Unsoeld

  • Tumor evasion from T cell surveillance.

    Katrin Töpfer;Stefanie Kempe;Nadja Müller;Marc Schmitz

  • Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia

    Jayakumar Vadakekolathu;Mark D. Minden;Tressa Hood;Sarah E. Church

  • Kit Regulates HSC Engraftment across the Human-Mouse Species Barrier

    Kadriye Nehir Cosgun;Susann Rahmig;Nicole Mende;Sören Reinke

  • A novel dendritic cell population in human blood: one-step immunomagnetic isolation by a specific mAb (M-DC8) and in vitro priming of cytotoxic T lymphocytes

    K Schäkel;E Mayer;C Federle;M Schmitz

  • Immunomodulatory Properties of Mesenchymal Stromal Cells: An Update.

    Luise Müller;Antje Tunger;Manja Wobus;Malte von Bonin;Malte von Bonin

  • The Bidirectional Crosstalk between Human Dendritic Cells and Natural Killer Cells

    Rebekka Wehner;Kristin Dietze;Michael Bachmann;Marc Schmitz

  • Modified vaccinia virus Ankara for delivery of human tyrosinase as melanoma-associated antigen: induction of tyrosinase- and melanoma-specific human leukocyte antigen A*0201-restricted cytotoxic T cells in vitro and in vivo.

    Ingo Drexler;Edite Antunes;Marc Schmitz;Thomas Wölfel

  • Generation of Cytotoxic Responses in Mice and Human Individuals Against Hematological Malignancies Using Survivin-RNA-Transfected Dendritic Cells

    Matthias Zeis;Sandra Siegel;Andreas Wagner;Marc Schmitz

  • Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: results of a phase I clinical trial.

    Susanne Fuessel;Axel Meye;Marc Schmitz;Stefan Zastrow

  • Long-Term Persistence of Monoclonal B Cells After Cure of Helicobacter pylori Infection and Complete Histologic Remission in Gastric Mucosa–Associated Lymphoid Tissue B-Cell Lymphoma

    Christian Thiede;Thomas Wündisch;Birgit Alpen;Beatrix Neubauer

  • Repression of NF-κB impairs HeLa cell proliferation by functional interference with cell cycle checkpoint regulators

    Barbara Kaltschmidt;Christian Kaltschmidt;S.P. Hehner;W. Dröge

  • Targeting of tumor cells expressing the prostate stem cell antigen (PSCA) using genetically engineered T-cells.

    Agnieszka Morgenroth;Marc Cartellieri;Marc Schmitz;Serap Günes

Frequent Co-Authors

Michael Bachmann
Michael Bachmann Helmholtz-Zentrum Dresden-Rossendorf
Anja Feldmann
Anja Feldmann Max Planck Society
Torsten Tonn
Torsten Tonn TU Dresden
Stefan Stevanovic
Stefan Stevanovic University of Tübingen
Jürgen Weitz
Jürgen Weitz TU Dresden
Sergio Rutella
Sergio Rutella Nottingham Trent University
Reinhard Ebner
Reinhard Ebner Human Genome Sciences (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can broaden career opportunities. Nursing is one of the closest allied fields, with various programs designed for different entry points and timelines. For individuals looking to advance quickly, programs like the easiest accelerated nursing programs offer a streamlined path to becoming a registered nurse.

Similarly, if you prefer starting with hands-on patient care roles, the fastest and easiest lpn programs provide accessible options to enter the nursing workforce with practical skills. These programs are ideal for gaining foundational knowledge pivotal in immunological patient management.

For advanced practice, the easiest np programs to get into can be a practical gateway. Nurse practitioner roles often collaborate with immunologists, especially in specialties like infectious diseases and immunotherapy.

For mental health enthusiasts, online options like the online pmhnp programs with clinical placement combine flexibility with hands-on experience. These programs prepare graduates to support patient immune health through mental wellness, a critical aspect of comprehensive healthcare.

Best Scientists Citing Marc Schmitz

Trending Scientists

Recently Published Articles